GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecure SA (WAR:MOC) » Definitions » Price-to-Tangible-Book

Molecure (WAR:MOC) Price-to-Tangible-Book : 4.81 (As of Jun. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Molecure Price-to-Tangible-Book?

As of today (2024-06-22), Molecure's share price is zł14.20. Molecure's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was zł2.95. Hence, Molecure's Price to Tangible Book Ratio of today is 4.81.

The historical rank and industry rank for Molecure's Price-to-Tangible-Book or its related term are showing as below:

WAR:MOC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.94   Med: 4.79   Max: 8.83
Current: 4.81

During the past 10 years, Molecure's highest Price to Tangible Book Ratio was 8.83. The lowest was 1.94. And the median was 4.79.

WAR:MOC's Price-to-Tangible-Book is ranked worse than
72.62% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs WAR:MOC: 4.81

A closely related ratio is called PB Ratio. As of today, Molecure's share price is zł14.20. Molecure's Book Value per Sharefor the quarter that ended in Mar. 2024 was zł5.59. Hence, Molecure's P/B Ratio of today is 2.54.


Molecure Price-to-Tangible-Book Historical Data

The historical data trend for Molecure's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecure Price-to-Tangible-Book Chart

Molecure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.92 5.26 4.52 2.67 5.05

Molecure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.06 5.61 3.53 5.05 5.85

Competitive Comparison of Molecure's Price-to-Tangible-Book

For the Biotechnology subindustry, Molecure's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecure's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecure's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Molecure's Price-to-Tangible-Book falls into.



Molecure Price-to-Tangible-Book Calculation

Molecure's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=14.20/2.952
=4.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Molecure Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Molecure's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecure (WAR:MOC) Business Description

Traded in Other Exchanges
N/A
Address
Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.